Skip to main content

Table 1 Patients demographics

From: Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy

 

Appropriate ICD therapy

No appropriate ICD therapy

P-value*

 

n = 7

n = 33

 

Age (year)

66 ± 10

61 ± 11

0.824

Sex (M), n (%)

6 (86)

23 (70)

0.323

ICM, n (%)

5 (71)

15 (45)

0.427

BiV, n (%)

2 (28)

9 (27)

0.729

Diabetes, n (%)

5 (71)

9(27)

0.081#

Hypertension, n (%)

6 (86)

24 (72)

0.819

Dyslipidemia, n (%)

3 (43)

18(54)

0.233

Beta-blocker, n (%)

5 (71)

30 (91)

0.453

ACE-inhibitor, n (%)

7 (100)

31 (94)

0.996

Anti-arrhythmic, n (%)

0

2 (6)

0.995

Aspirin, n (%)

5 (71)

26 (79)

0.493

Pre-ICD NYHA

3 ± 1

3 ± 1

0.810

Inappropriate ICD therapy

0

2 (6)

0.996

  1. BiV: Biventricular pacemaker; ICM: ischemic cardiomyopathy; ACE: angiotensin converting enzyme; Echo: echocardiography; NYHA: new york heart association.
  2. * Univariate Cox’s proportional hazard model.
  3. # was considered clinically significant and was entered into the multivar model.